22 febrero 2020

Yondelis + Radioterapia . Phenomenal Results in Phase 1/2 TRASTS Study in Metastatic Sarcoma ! . 72% Overall Response Rate with Trabectedin + Radiotherapy (30 Gy/10 fxn) .